BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 2468803)

  • 1. [Relationship between proteinase inhibitory activity of plasma alpha 2-macroglobulin and depressed cell immunity in idiopathic nephrotic syndrome].
    Asami T; Nisihara T; Hayashi M; Sakai K
    Nihon Jinzo Gakkai Shi; 1988 Aug; 30(8):935-41. PubMed ID: 2468803
    [No Abstract]   [Full Text] [Related]  

  • 2. Study on proteinase-inhibiting capacity of plasma alpha 2-macroglobulin in idiopathic nephrotic syndrome.
    Asami T; Nishihara T; Tomisawa S; Sakai K; Uchiyama M
    Nephron; 1996; 72(4):512-7. PubMed ID: 8730413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma levels and urinary excretion of fibrinolytic and protease inhibitory proteins in nephrotic syndrome.
    Vaziri ND; Gonzales EC; Shayestehfar B; Barton CH
    J Lab Clin Med; 1994 Jul; 124(1):118-24. PubMed ID: 7518491
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Kinin system components, free kinins and proteinase inhibitors in the edematous fluids of nephrotic syndrome patients].
    Paskhina TS; Poliantseva AR; Egorova TP; Krinskaia AV; Nartikova VF
    Vopr Med Khim; 1979; 25(5):588-99. PubMed ID: 91261
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Decreased plasma alpha 1-proteinase inhibitor activity in idiopathic nephrotic syndrome].
    Asami T; Nishihara T; Fujii M; Sakai K
    Nihon Jinzo Gakkai Shi; 1989 Mar; 31(3):301-7. PubMed ID: 2786967
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Cellular immunity in idiopathic nephrotic syndrome with minimal glomerular lesions and focal and segmental hyalinosis in children].
    Batellier H; Dechelette E; Bensa JC; Bost M
    Arch Fr Pediatr; 1983 Mar; 40(3):149-55. PubMed ID: 6603829
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Age-dependent changes in inhibitory effect of human sera on phytohemagglutinin (PHA)-stimulated lymphocyte proliferation: its relationship to serum alpha 2-macroglobulin.
    Oshida Y; Hiratani M; Muto K; Ito S; Kasei M
    Arerugi; 1985 Jan; 34(1):62-9. PubMed ID: 2581529
    [No Abstract]   [Full Text] [Related]  

  • 8. [Detection of the degree of activity of ulcerative colitis. Behavior of serum alpha 1-proteinase inhibitor and alpha 2-macroglobulin].
    Amiguet JA; Sagüés J; Muñoz MA; Zozaya J; Conchillo F
    Rev Esp Enferm Apar Dig; 1989 Apr; 75(4):345-7. PubMed ID: 2472652
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell mediated immunity in idiopathic glomerulonephritis.
    Sasdelli M; Cagnoli L; Candi P; Mandreoli M; Beltrandi E; Zucchelli P
    Clin Exp Immunol; 1981 Oct; 46(1):27-34. PubMed ID: 6978215
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of endogenous proteinase inhibitors in the regulation of the blood clotting system of the horseshoe crab, Limulus polyphemus.
    Armstrong PB; Levin J; Quigley JP
    Thromb Haemost; 1984 Oct; 52(2):117-20. PubMed ID: 6084318
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Immunosuppressive activity of serum from patients with idiopathic nephrotic syndrome].
    Inoue K; Matsuo H; Yamashita F
    Nihon Jinzo Gakkai Shi; 1982 Nov; 24(11):1243-50. PubMed ID: 7166890
    [No Abstract]   [Full Text] [Related]  

  • 12. [Significance of immunoreactive alpha 2-macroglobulin in health and disease].
    Wagner V; Wagnerová M
    Cas Lek Cesk; 1977 May; 116(19):580-3. PubMed ID: 69497
    [No Abstract]   [Full Text] [Related]  

  • 13. Alpha 2-macroglobulin and pregnancy zone protein. Serum levels, alpha 2-macroglobulin receptors, cellular synthesis and aspects of function in relation to immunology.
    Petersen CM
    Dan Med Bull; 1993 Sep; 40(4):409-46. PubMed ID: 7693397
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Howie's antithrombin activity and thrombin inhibitors in the nephrotic syndrome].
    Campo G; Modena N; Gallo A; Ciaffoni S
    Quad Sclavo Diagn; 1985 Mar; 21(1):106-16. PubMed ID: 2414802
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glomerular deposition of alpha 2-macroglobulin in a child with steroid refractory nephrotic syndrome.
    Asami T; Ohsawa S; Tomisawa S; Hashimoto K; Toyabe S; Sakai K
    Nephron; 1992; 61(2):211-3. PubMed ID: 1378560
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibitory factors of lymphocyte transformation in sera from patients with minimal change nephrotic syndrome.
    Beale MG; Hoffsten PE; Robson AM; MacDermott RP
    Clin Nephrol; 1980 Jun; 13(6):271-6. PubMed ID: 6447569
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiple serum inhibitors of lectin-induced lymphocyte proliferation in nephrotic syndrome.
    Martini A; Vitiello MA; Siena S; Capelli V; Ugazio AG
    Clin Exp Immunol; 1981 Jul; 45(1):178-84. PubMed ID: 7307346
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cell-mediated immunity and effects of cyclophosphamide on primary nephrotic syndrome (author's transl)].
    Okura T; Matsuo S; Kumon S; Hibi I; Tamaki S; Watanabe Y; Kinoshita Y
    Nihon Jinzo Gakkai Shi; 1981 Nov; 23(11):1395-403. PubMed ID: 7334719
    [No Abstract]   [Full Text] [Related]  

  • 19. Increased serum and urinary neopterin in nephrotic syndrome indicate cell-mediated immune dysfunction.
    Oda K; Arai T; Nagase M
    Am J Kidney Dis; 1999 Oct; 34(4):611-7. PubMed ID: 10516339
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of progressive antithrombin activity and the concentration of three thrombin inhibitors in nephrotic syndrome.
    Boneu B; Bouissou F; Abbal M; Sie P; Caranobe C; Barthe P
    Thromb Haemost; 1981 Oct; 46(3):623-5. PubMed ID: 6171906
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.